 Lineage Cell Therapeutics, Inc. NYSE American and TASE: LCTX, a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that it will report its second quarter 2020 financial and operating results on Thursday, August 6, 2020, following the close of the U.S. financial markets. Lineage management will also host a conference call and webcast on Thursday, August 6, 2020, at 5:30 p.m. Eastern Time2:30 p.m. Pacific Time to discuss its second quarter 2020 financial and operating results and to provide a business update. 